Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Cirrhotic Subjects With Chronic Genotype 1 HCV Infection
Clinical trial NCT01965535 · COMPLETED
Trial details
- NCT number
- NCT01965535
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2014-08-01
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.